Grove Bank & Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152 | Sell |
1
-19
| -95% | -$2.89K | ﹤0.01% | 848 |
|
|
2025
Q1 | $3.01K | Buy |
20
+12
| +150% | +$1.81K | ﹤0.01% | 739 |
|
|
2024
Q4 | $1.48K | Buy |
8
+1
| +14% | +$185 | ﹤0.01% | 706 |
|
|
2024
Q3 | $1.38K | Buy |
+7
| New | +$1.38K | ﹤0.01% | 692 |
|
|
2022
Q1 | – | Sell |
-680
| Closed | -$256K | – | 231 |
|
|
2021
Q4 | $256K | Hold |
680
| – | – | 0.05% | 204 |
|
|
2021
Q3 | $281K | Hold |
680
| – | – | 0.06% | 194 |
|
|
2021
Q2 | $252K | Buy |
+680
| New | +$252K | 0.05% | 192 |
|
|
2018
Q1 | – | Sell |
-680
| Closed | -$74K | – | 230 |
|
|
2017
Q4 | $74K | Hold |
680
| – | – | 0.03% | 255 |
|
|
2017
Q3 | $73K | Buy |
680
+100
| +17% | +$10.7K | 0.04% | 257 |
|
|
2017
Q2 | $59K | Buy |
580
+90
| +18% | +$9.16K | 0.04% | 235 |
|
|
2017
Q1 | $44K | Hold |
490
| – | – | 0.04% | 227 |
|
|
2016
Q4 | $37K | Buy |
+490
| New | +$37K | 0.03% | 261 |
|